Awakn Life Sciences Corp. (AWKNF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -3.9 Million CAD | 25.75% |
| 2023 | -5.26 Million CAD | 10.66% |
| 2022 | -16.08 Million CAD | -1044.06% |
| 2021 | -840.21 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - CAD | 54.49% |
| 2024 Q4 | -837.63 Thousand CAD | -25.28% |
| 2024 Q3 | -668.62 Thousand CAD | 54.18% |
| 2024 Q2 | -1.45 Million CAD | -54.81% |
| 2024 Q1 | -1.77 Million CAD | 57.05% |
| 2023 FY | - CAD | 10.66% |
| 2023 Q3 | -1.73 Million CAD | 19.6% |
| 2023 Q4 | -2.19 Million CAD | -26.73% |
| 2023 Q2 | -2.15 Million CAD | 14.1% |
| 2023 Q1 | -2.5 Million CAD | 35.09% |
| 2022 Q3 | -2.83 Million CAD | -63.83% |
| 2022 Q2 | -1.72 Million CAD | -45.94% |
| 2022 Q1 | -1.18 Million CAD | -85.8% |
| 2022 FY | - CAD | -1044.06% |
| 2022 Q4 | -3.86 Million CAD | -36.31% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q4 | -637.98 Thousand CAD | -331.68% |
| 2021 Q2 | -456.81 Thousand CAD | 0.0% |
| 2021 Q3 | -147.79 Thousand CAD | 67.65% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 94.498% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 34.082% |
| SQZ Biotechnologies Company | -64.14 Million USD | 93.907% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 77.5% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 104.156% |
| Mesoblast Limited | -62.38 Million USD | 93.736% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -154.432% |
| Genus plc | 73.7 Million USD | 105.303% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 40.888% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -10.183% |
| Marizyme, Inc. | -34.28 Million USD | 88.6% |
| ContraFect Corporation | -64.99 Million USD | 93.987% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 55.447% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 13.654% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -178.797% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -47.789% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -68.18% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -654.411% |
| Accustem Sciences Inc. | -3.74 Million USD | -4.318% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 91.896% |
| EV Biologics, Inc. | -1.26 Million USD | -208.429% |
| Q BioMed Inc. | -617.62 Thousand USD | -532.775% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 209.412% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -517.989% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -71.075% |
| Biomind Labs Inc. | -1.03 Million USD | -277.768% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 139.569% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 45.426% |
| Skye Bioscience, Inc. | -13.54 Million USD | 71.152% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -162.751% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -15532.788% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -0.615% |
| IMV Inc. | -35.52 Million USD | 88.998% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 75.373% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -56.205% |
| GB Sciences, Inc. | -1.41 Million USD | -175.247% |
| Alpha Cognition Inc. | -9.7 Million USD | 59.733% |
| HST Global, Inc. | -5303.00 USD | -73597.85% |
| CSL Limited | 4.78 Billion USD | 100.082% |
| Halberd Corporation | -74.27 Thousand USD | -5161.51% |
| Enzolytics Inc. | -2.12 Million USD | -84.173% |
| Resverlogix Corp. | -11.74 Million USD | 66.716% |
| Affymax, Inc. | -14.29 Million USD | 72.66% |
| SYBLEU INC | -141.57 Thousand USD | -2660.592% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -27.593% |
| argenx SE | -216.02 Million USD | 98.191% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 92.938% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 421.134% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -160.737% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 1131.611% |
| AVAX Technologies, Inc. | -6.11 Million USD | 36.064% |
| Zenith Capital Corp. | -8.6 Million USD | 54.588% |
| Genscript Biotech Corporation | -248.71 Million USD | 98.429% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -22333.827% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -59.749% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -2120.259% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 90.14% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -35.123% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -273.521% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 58223.096% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -123.326% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -103.455% |
| BioStem Technologies, Inc. | -7.55 Million USD | 48.261% |
| ONE Bio Corp. | 13.61 Million USD | 128.709% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -2058.176% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -89.995% |
| Agentix Corp. | -1.37 Million USD | -184.905% |
| LadRx Corporation | 412.28 Thousand USD | 1047.94% |
| Cell Source, Inc. | -4.27 Million USD | 8.527% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -964.263% |
| Regen BioPharma, Inc. | 1.46 Million USD | 366.597% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -317.12% |
| NovAccess Global Inc. | -1.03 Million USD | -277.678% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 144.141% |
| Itoco Inc. | -1.86 Million USD | -109.107% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -929.502% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -250.197% |
| Kadimastem Ltd | -2.62 Million USD | -48.919% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -1534.203% |
| CytoDyn Inc. | -18.02 Million USD | 78.323% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -4845.269% |
| Mobile Lads Corp. | -2.24 Million USD | -74.383% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -31858.435% |
| Qrons Inc. | -40.08 Thousand USD | -9650.747% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -704.689% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 840.985% |
| Rebus Holdings, Inc. | -951 Thousand USD | -310.957% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -268.0% |
| International Stem Cell Corporation | 202 Thousand USD | 2034.751% |
| Bioxytran, Inc. | -3.82 Million USD | -2.305% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -7324.386% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -58.745% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 89.104% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -8584.882% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -42.739% |
| Neutra Corp. | -181.24 Thousand USD | -2056.282% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 80.613% |
| PureTech Health plc | -11.62 Million USD | 66.387% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 80.612% |
| IXICO plc | -707 Thousand USD | -452.786% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 49.145% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 91.916% |
| CSL Limited | 4.73 Billion USD | 100.083% |
| Cellectis S.A. | -92.63 Million USD | 95.781% |